Sign in

Lost your password?
(close)

Resources > Country Reports



Following a battering by the 2008 global financial crisis and the austerity policies the country was forced to implement, Romania’s economy has rebounded well over the past few years, allowing the oft-overlooked Eastern European country to top the European Union table with…

Home to a USD 3.38 billion pharma market, one of Central and Eastern Europe’s most high-performing healthcare systems, and one of the region’s leading economies, the Czech Republic’s healthcare and life sciences market is fast closing the gap on its Western European…

The UAE’s pharma market was predicted to grow to USD four billion in 2020, representing a CAGR of 8.5 percent from 2019. The country sits at the heart of the Middle East which, although only making up two percent of the global pharmaceutical industry, has been growing at a…

In line with its status as one of Europe’s most dynamic economies, Hungary is aiming to boost both its life sciences industry and the level of healthcare it provides to its citizens. Year-on-year GDP growth stood at 4.8 percent in 2019, driven on by a burgeoning domestic…

This new issue of China Healthcare and Life Sciences Review (compiled in December 2019) provides a retrospective of the tremendous gains the Chinese healthcare industry made in 2019 while simultaneously anticipating the challenges and opportunities on the horizon in the new…

Puerto Rico has a stronger healthcare manufacturing footprint than any other US jurisdiction or State, with 50 pharma and 30 medical device sites dotted throughout the island. This footprint represents around 30 percent of Puerto Rico’s GDP and two of its major exports.…

Belying its small size, the Nordic nation of Sweden punches well above its weight in scientific innovation. Nowhere is this Swedish spirit of innovation more keenly felt than in the country’s healthcare and life sciences industry. As the nation that introduced some of the…

Long overshadowed by larger and more well-known neighbours, the island of Taiwan is nonetheless cultivating an enviable reputation at the forefront of some of the most innovative trends shaping global healthcare today. From artificial intelligence to blockchain, the…

Thailand is in the midst of an economic transformation with healthcare at its heart. ASEAN’s second largest economy has implemented an ‘Industry 4.0’ policy through which it is attempting to prioritise R&D and innovation in a number of key industries, including…

With optimism and energy pervading the Chinese healthcare landscape, actors of all stripes see new potential and opportunities on the horizon. The heterogeneity of the Chinese market, with its 31 province-level entities offering a variety of market characteristics and needs;…

Building on the topics covered in our March 2019 report, this latest edition of Healthcare & Life Sciences Review Spain takes a closer look at the broader Spanish life sciences value chain. With the Iberian nation enjoying an economic rebound, pharmaceutical…

Now enjoying a period of relative political stability and with a swathe of economic reforms in the pipeline, Egypt is once more becoming one of the most favourable investment destinations in its region. Nowhere is this trend more apparent than in healthcare. With the…

We use cookies to ensure that we give you the best experience on our site. For more info click here